Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Jun 21;15(13):2830.
doi: 10.3390/nu15132830.

Effect of Vitamin D Supplementation on Primary Dysmenorrhea: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Affiliations
Meta-Analysis

Effect of Vitamin D Supplementation on Primary Dysmenorrhea: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Yi-Chun Chen et al. Nutrients. .

Abstract

Dysmenorrhea causes pain and inconvenience during menstruation. In addition to medication, natural compounds are widely used to relieve various types of pain. In this study, we aimed to assess the effects of vitamin D (vit. D) supplementation in relieving the symptoms of primary dysmenorrhea. A comprehensive systematic database search of randomized controlled trials (RCTs) was performed. Oral forms of vit. D supplementation were included and compared with a placebo or standard care. The degree of dysmenorrhea pain was measured with a visual analogue scale or numerical rating scale. Outcomes were compared using the standardized mean difference (SMD) and 95% confidence intervals (CIs) in a meta-analysis. RCTs were assessed using the Cochrane risk-of-bias v2 (RoB 2) tool. The meta-analysis included 8 randomized controlled trials involving 695 participants. The results of the quantitative analysis showed a significantly lower degree of pain in the vit. D versus placebo in those with dysmenorrhea (SMD: -1.404, 95% CI: -2.078 to -0.731). The results of subgroup analysis revealed that pain lessened when the average weekly dose of vit. D was over 50,000 IU, in which dysmenorrhea was relieved regardless of whether vit. D was administered for more or less than 70 days and in any dose interval. The results revealed that vit. D treatment substantially reduced the pain level in the primary dysmenorrhea population. We concluded that vit. D supplementation is an alternative treatment for relieving the pain symptoms of dysmenorrhea.

Keywords: Cochrane risk-of-bias (RoB 2); dysmenorrhea; pain degree; pain relief; randomized controlled trials (RCTs); systemic review meta-analysis (SRMA); vitamin D.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow chart outlining literature search screening and selection procedure.
Figure 2
Figure 2
Forest plot intercept of the effect of vit. D interventions on pain relief in primary dysmenorrhea. Data were obtained from 9 published RCTs studies using the linear regression of the intervention effect Egger’s test. The pooled effect is represented using a black-colored solid diamond. The location of the diamond represents the estimated effect size and the width of the diamond reflects the precision of the estimate. The black-colored solid square marker size representing the effect size all have the same size and vary in size according to the weights assigned to the different studies. [Std diff, standardized difference.].
Figure 3
Figure 3
Contour-enhanced funnel: Egger’s plot of standard error (y-axis) by the standard difference in means (odds ratios x-axis). The vertical and diagonal lines represent the overall estimated effect size and its 95% confidence limits, respectively, based on the fixed-effect model. The shaded regions represent different significance levels for the effect size. [Std diff, standardized difference.].

Similar articles

Cited by

References

    1. Proctor M., Farquhar C. Diagnosis and management of dysmenorrhoea. BMJ. 2006;332:1134–1138. doi: 10.1136/bmj.332.7550.1134. - DOI - PMC - PubMed
    1. Burnett M., Lemyre M. No. 345-primary dysmenorrhea consensus guideline. J. Obstet. Gynaecol. Can. 2017;39:585–595. doi: 10.1016/j.jogc.2016.12.023. - DOI - PubMed
    1. Iacovides S., Avidon I., Baker F.C. What we know about primary dysmenorrhea today: A critical review. Hum. Reprod. Update. 2015;21:762–778. doi: 10.1093/humupd/dmv039. - DOI - PubMed
    1. Nnoaham K.E., Hummelshoj L., Webster P., d’Hooghe T., de Cicco Nardone F., de Cicco Nardone C., Jenkinson C., Kennedy S.H., Zondervan K.T. Impact of endometriosis on quality of life and work productivity: A multicenter study across ten countries. Fertil. Steril. 2011;96:366–373.e368. doi: 10.1016/j.fertnstert.2011.05.090. - DOI - PMC - PubMed
    1. Ayan M., Sogut E., Tas U., Erdemir F., Sahin M., Suren M., Kaya Z., Demirturk F. Pain levels associated with renal colic and primary dysmenorrhea: A prospective controlled study with objective and subjective outcomes. Arch. Gynecol. Obstet. 2012;286:403–409. doi: 10.1007/s00404-012-2316-4. - DOI - PubMed